Parkway Life Real Estate Investment Trust
SGX:C2PU
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Parkway Life Real Estate Investment Trust
SGX:C2PU
|
SG |
|
R
|
Reata Pharmaceuticals Inc
F:2R3
|
US |
|
A
|
Adventa Bhd
KLSE:ADVENTA
|
MY |
|
Micro-Mechanics Holdings Ltd
SGX:5DD
|
SG |
Wall Street
Price Targets
C2PU Price Targets Summary
Parkway Life Real Estate Investment Trust
According to Wall Street analysts, the average 1-year price target for
C2PU
is 4.92
with a low forecast of 4.15 and a high forecast of 5.72 .
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is C2PU's stock price target?
Price Target
4.92
According to Wall Street analysts, the average 1-year price target for
C2PU
is 4.92
with a low forecast of 4.15 and a high forecast of 5.72 .
What is Parkway Life Real Estate Investment Trust's Revenue forecast?
Projected CAGR
5%
For the last 14 years the
compound annual growth rate for
Parkway Life Real Estate Investment Trust's revenue is
4%.
The projected
CAGR
for the next 3 years is
5%.
What is Parkway Life Real Estate Investment Trust's Operating Income forecast?
Projected CAGR
5%
For the last 14 years the
compound annual growth rate for
Parkway Life Real Estate Investment Trust's operating income is
4%.
The projected
CAGR
for the next 3 years is
5%.
What is Parkway Life Real Estate Investment Trust's Net Income forecast?
Projected CAGR
-7%
For the last 14 years the
compound annual growth rate for
Parkway Life Real Estate Investment Trust's net income is
3%.
The projected
CAGR
for the next 3 years is
-7%.
